| Sep-2024 | Jun-2024 | Mar-2024 | Dec-2023 | Sep-2023 | |
|---|---|---|---|---|---|
Promoter | - | - | - | - | - |
Foreign | 0% | 0% | 0% | 0% | 0% |
Indian | 72.86% | 73.46% | 73.58% | 73.58% | 73.58% |
Total Promoter | - | - | - | - | - |
Institutions | 1.53% | 1.33% | 1.1% | 0.95% | 0.83% |
Non-Institutions | 25.59% | 25.2% | 25.3% | 25.45% | 25.57% |
Total Non-Promoter | 27.13% | 26.53% | 26.41% | 26.41% | 26.41% |
Custodian | 0% | 0% | 0% | 0% | 0% |
Total | 100% | 100% | 100% | 100% | 100% |
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice
